all names

Merck organisation

Named in 55 reports across 10 stories - 17 Aug – 24 Oct
17 Aug 202624 Oct 2026
6 edits, 1 URL changed7 entries
  1. ANSA (Italy)seen 8 Oct, 00:21description editedthe story
  2. ABC (Spain)seen 24 Aug, 16:25headline rewrittenthe story

    Lo que aún no sabemos de la vacuna que quiere revolucionar el tratamiento del cáncer contra el melanomaLas claves de la vacuna contra el melanoma

  3. Libération (France)seen 23 Aug, 05:07headline rewrittenthe story

    Cancer de la peau : un vaccin à ARN messager testé par Moderna et Merck pourrait repousser de manière «significative» la récidiveCancer de la peau : un vaccin à ARN messager testé par Moderna et Merck pourrait diminuer de manière «significative» la récidive

  4. ANSA (Italy)seen 21 Aug, 23:48URL changedthe story
  5. Libération (France)seen 20 Aug, 17:56headline rewrittenthe story

    Cancer de la peau : un vaccin à ARN messager testé par Moderna et Merck pourrait diminuer de manière «significative» le risque de récidiveCancer de la peau : un vaccin à ARN messager testé par Moderna et Merck pourrait repousser de manière «significative» la récidive

  6. ANSA (Italy)seen 19 Aug, 21:52headline rewrittenthe story

    Il vaccino contro il melanoma mostra risultati promettenti, Moderna vola in Borsa a +130%Successo del farmaco antimelanoma, Moderna strappa a Wall Street

  7. El País (Spain)seen 19 Aug, 21:52headline rewrittenthe story

    El anuncio del éxito de la primera vacuna contra el melanoma dispara las acciones de Moderna y MerckModerna y Merck anuncian el éxito de la primera vacuna personalizada contra el melanoma y sus acciones se disparan en Bolsa

Closest companions, sized by how often they share a report with Merck. Lines between the outer names are their own relationships - names that appear together even without Merck.

CNBC and Moderna share 8 reportsModerna and WSJ share 7 reportsModerna and Yahoo Finance share 5 reportsModerna and Wall Street share 4 reportsArs Technica and Moderna share 4 reportsWSJ and Yahoo Finance share 3 reportsModerna and STAT share 2 reportsModerna and MSD share 2 reportsCNBC and Wall Street share 1 reportArs Technica and CNBC share 1 reportCNBC and WSJ share 1 reportCNBC and Yahoo Finance share 1 reportCNBC and STAT share 1 reportArs Technica and MSD share 1 reportEurope and STAT share 1 reportArs Technica and WSJ share 1 reportArs Technica and Yahoo Finance share 1 reportSTAT and Yahoo Finance share 1 reportBolsa and MSD share 1 reportWall Street and Yahoo Finance share 1 reportCNBC and MSD share 1 reportSTAT and WSJ share 1 reportBolsa and Moderna share 1 reportMerckModernaModerna - 36 shared reports (organization)CNBCCNBC - 8 shared reports (organization)WSJWSJ - 8 shared reports (organization)EuropeEurope - 5 shared reports (place)Wall StreetWall Street - 5 shared reports (place)Yahoo FinanceYahoo Finance - 5 shared reports (organization)Ars TechnicaArs Technica - 4 shared reports (organization)MSDMSD - 4 shared reports (organization)STATSTAT - 3 shared reports (organization)BolsaBolsa - 2 shared reports (place)

The stories

Top 10 Stocks

359 outlets1 report names Merck2 Dec 2025 – 8 Nov 2026

Increasingly hot Europe faces more severe droughts and growing challenges for water and land management

123 outlets4 reports name Merck23 Jul – 30 Oct

Biofrontera Inc. to Report Second Quarter 2026 Financial Results on August 13, 2026

74 outlets1 report names Merck5 Aug – 7 Nov

Trump Administration Considers Order on Autism and Vaccines

76 outlets1 report names Merck6 Aug – 25 Aug

Tumor treatment, the turning point. The era of personalized mRNA vaccines begins

34 outlets4 reports name Merck13 Sept – 7 Nov

Merck and Moderna Announce Phase 3 INTerpath-001 Trial of Intismeran Autogene Plus KEYTRUDA® Met Endpoints of Recurrence-Free Survival (RFS) and Distant Metastasis-Free Survival (DMFS) in Patients With Completely Resected Stage IIB-IV Melanoma

43 outlets30 reports name Merck19 Aug – 27 Aug

F.D.A. Approves Moderna’s mRNA Flu Vaccine

19 outlets1 report names Merck6 Aug – 30 Aug

Cancer Vaccines Are the N.I.H’s Next ‘Big Bet’

10 outlets9 reports name Merck9 Oct – 27 Oct

Cuaz Brings Policy Expertise to European Plastics Group

3 outlets3 reports name Merck1 Sept – 4 Nov

Halozyme stymies subcutaneous Keytruda launch in select European countries as Merck vows to fight patent claims

1 outlets1 report names Merck7 Oct

Who keeps naming them

Google News - Top Stories20Google News - Europe query8ANSA (Italy)2South China Morning Post2France Info (France)2El País (Spain)2Libération (France)2ABC (Spain)2The Hill1Il Fatto Quotidiano (Italy)1Al Jazeera English1MercoPress (South America)1

One email a week

The stories everytrace watched stay alive - how many independent outlets carried each one, and how long it lasted. No daily digest, no breaking-news alerts.